For research use only. Not for therapeutic Use.
Levetiracetam (Cat No.: A000496) is an anticonvulsant medication used to treat various types of seizures, including partial-onset, myoclonic, and generalized tonic-clonic seizures in both adults and children. Its precise mechanism is not fully understood, but it is believed to modulate synaptic neurotransmitter release by binding to the SV2A protein in the brain. Levetiracetam is available in oral and intravenous forms and is generally well-tolerated. Common side effects include drowsiness, dizziness, and irritability. It has minimal drug interactions, making it suitable for combination therapy.
CAS Number | 102767-28-2 |
Synonyms | 102767-28-2; Keppra; (S)-2-(2-Oxopyrrolidin-1-yl)butanamide; Keppra XR; Levetiracetamum |
Molecular Formula | C8H14N2O2 |
Purity | ≥95% |
Storage | -20°C |
IUPAC Name | (2S)-2-(2-oxopyrrolidin-1-yl)butanamide |
InChI | 1S/C8H14N2O2/c1-2-6(8(9)12)10-5-3-4-7(10)11/h6H,2-5H2,1H3,(H2,9,12)/t6-/m0/s1 |
InChIKey | HPHUVLMMVZITSG-LURJTMIESA-N |
SMILES | CCC(C(=O)N)N1CCCC1=O |
Reference | 1: Dircio-Bautista M, Colín-González AL, Aguilera G, Maya-López M, 2: Barnard L, Barnes Heller H, Boothe DM. Pharmacokinetics of Single Oral Dose 3: Premoli I, Costantini A, Rivolta D, Biondi A, Richardson MP. The Effect of 4: Shastay A. Prescribing Errors With LevETIRAcetam Oral Solution. Home Healthc 5: Kanda J, Izumo N, Kobayashi Y, Onodera K, Shimakura T, Yamamoto N, Takahashi 6: Yan BC, Shen H, Zhang Y, Zhu X, Wang J, Xu P, Jiang D, Yu X. The antiepileptic 7: Feyissa AM. Antiepileptic drug-related neuropsychiatric adverse events in <br> 9: Kakisaka Y, Jin K, Fujikawa M, Kitazawa Y, Kato K, Nakasato N. Levetiracetam 10: Hau Man TH, Shek-Kwan CR, On-Kei CA, Lam CPW. Effect of plasmapheresis on |
Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |